HIL makes the shortlist of the Future Planet Awards 2018 HIL was shortlisted for the second annual Future Planet Awards, a prize given to startups that

HIL awarded two new US patents. These two latest additions – granted to HIL during the past two months – bring HIL’s patent portfolio to

HIL scientists publish a paper in HPLSE Journal Omer Shavit, Yair Ferber, Evgeny Papeer, Arie Zigler – all R&D Physicists at HIL, – et. al.

Mr. Lior Buchman (CPA) joins HIL’s Board of Directors Mr. Buchman has over 20 years of experience in senior corporate financing, mergers & acquisitions, investor relations,

HIL is awarded a European Union R&D grant under Horizon 2020 Horizon 2020 is the EU’s framework programme for research and innovation. According to the

HIL named one of 10 Coolest Biotech Companies in Jerusalem ISRAL21c, together with JLM-BioCity today shared their thoughts on the Coolest Biotech Companies in Jerusalem.

HIL Medical and University of Nevada announce collaboration Win-win-win: Nevada Terawatt Facility hosts research, Israeli-based company invests in equipment and proton-therapy advances for cancer treatment.

HIL issued US patent #9711319 With over 25 granted and pending patents worldwide, and significant know-how and expertise – unique and highly specialized – HIL